← Eichor
Condition: Bipolar Disorder I Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Bipolar Disorder I

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
Phase 3 · 68 location(s) · Intra-Cellular Therapies, Inc. · NCT06372964Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder
Phase 1 · 5 location(s) · BioXcel Therapeutics Inc · NCT05025605Feasibility and Preliminary Results of the Efficacy of Blue-Blocking Glasses on Manic Symptoms in Bipolar Disorder
NA · 1 location(s) · Centre Hospitalier St Anne · NCT07194278Pharmacokinetics, Safety, Tolerability and Efficacy of a Subcutaneous Long-Acting Injection of Cariprazine (Cariprazine
Phase 1/Phase 2 · 6 location(s) · Mapi Pharma Ltd. · NCT07185815A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Ep
Phase 3 · 81 location(s) · AbbVie · NCT04777357Decoding Emotional Dynamics in Bipolar Disorder
NA · 1 location(s) · Laureate Institute for Brain Research, Inc. · NCT07221864A Study of Abilify® Tablet(Aripiprazole) as an Adjunctive Treatment in the Bipolar Depression
Phase 3 · 1 location(s) · Korea Otsuka Pharmaceutical Co., Ltd. · NCT03423680Ketogenic and Nutritional Interventions for First Episode Bipolar Disorder
NA · 1 location(s) · Mclean Hospital · NCT06221852Brexpiprazole Treatment for Bipolar I Depression
Phase 3 · 3 location(s) · Douglas Mental Health University Institute · NCT04569448Cerebellar Modulation of Cognition in Psychosis
NA · 2 location(s) · Mclean Hospital · NCT06107764Magnetic Resonance-Guided Focused Ultrasound Bilateral Capsulotomy for the Treatment of Refractory Bipolar Depression
NA · 1 location(s) · Sunnybrook Health Sciences Centre · NCT07108257A Study to Investigate Lithium Brain/Plasma Pharmacokinetics and Safety of an AL001 Oral Capsule Compared to a Marketed
Phase 1/Phase 2 · 1 location(s) · Alzamend Neuro, Inc. · NCT07540338A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipola
Phase 3 · 28 location(s) · Xenon Pharmaceuticals Inc. · NCT07172516Evaluation of the Efficacy, Safety, and Tolerability of Lacosamide in Major Depressive Episodes of Bipolar Disorder Type
Phase 3 · 1 location(s) · University of Sao Paulo · NCT07412132An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Ma
Phase 2 · 6 location(s) · Neurocrine Biosciences · NCT07288320A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2
Phase 3 · 85 location(s) · Bristol-Myers Squibb · NCT06951711ALTO-100 in Bipolar Disorder With Depression (BD-D)
Phase 2 · 27 location(s) · Alto Neuroscience · NCT06656416A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder
Phase 3 · 73 location(s) · Bristol-Myers Squibb · NCT06951698Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I
Phase 3 · 47 location(s) · Alkermes, Inc. · NCT05303064Integrated Care for Older Adults With Major Depression and Physical Multimorbidity - The I-CONNECT
NA · 1 location(s) · KU Leuven · NCT07211750A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I
Phase 2 · 33 location(s) · AbbVie · NCT06696755Norwegian Mental Illness Heart Health Study
NA · 1 location(s) · Madeleine Elisabeth Angelsen · NCT07085923Children's Bipolar Network Treatment Trial I
Phase N/A · 4 location(s) · University of California, Los Angeles · NCT05427123NMDA Receptor Modulation for the Treatment of Bipolar I Disorder
Phase 2 · 1 location(s) · China Medical University Hospital · NCT05977023Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.
Phase 2 · 26 location(s) · LB Pharmaceuticals Inc. · NCT07494305A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Phase 3 · 174 location(s) · Bristol-Myers Squibb · NCT06929273A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Featur
Phase 3 · 104 location(s) · Bristol-Myers Squibb · NCT07140913Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipol
Phase 2 · 49 location(s) · AbbVie · NCT07220460LHC-CIDI-5 in Hong Kong
Phase N/A · 1 location(s) · The University of Hong Kong · NCT06804525Effectiveness of Digital Cognitive Behavioral Therapy for the Treatment of Depression: a Real-world Study
NA · 1 location(s) · Peking University · NCT06831435
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.